Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo

Author： Perabo F.G.E. Mattes R.H. Wirger A. Steiner G. Kamp S. Schmidt D. Pegelow K. von Ruecker A. Muller S.C.

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.6, Iss.4, 2001-07, pp. : 163-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD4⁺ T cells kill Id⁺ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo

By Lundin Katrin Screpanti Valentina Omholt Hilde Hofgaard Peter Yagita Hideo Grandien Alf Bogen Bjarne

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 12, 2004-12 ,pp. : 1135-1145

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of Fas and Fas ligand expression and function in lung cancer cell lines

By Kawasaki M. Kuwano K. Nakanishi Y. Hagimoto N. Takayama K. Pei X.-H. Maeyama T. Yoshimi M. Hara N.

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 656-663

Elsevier

Access to resources Recommend Favorite

Isolinderalactone inhibits proliferation of A549 human nonsmall cell lung cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway

Molecular Medicine Reports, Vol. 9, Iss. 5, 2014-01 ,pp. : 1653-1659

Spandidos Publications

Access to resources Recommend Favorite

Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 645-654

Spandidos Publications

Access to resources Recommend Favorite

Activation of Fas Ligand/Receptor System Kills Ovarian Cancer Cell Lines by an Apoptotic Mechanism

By Ghahremani M. Foghi A. Dorrington J.H.

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 275-281

Elsevier

Access to resources Recommend Favorite